ATHEROSCLEROSIS
Clinical trials for ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to stabilize dangerous heart plaques
Disease control Recruiting nowThis early-stage study tests an injectable drug called IMC-001 in 18 people who recently had a heart attack or unstable angina. The goal is to see if it can make fatty plaques in the arteries more stable and less likely to cause future problems. Participants receive either the dr…
Matched conditions: ATHEROSCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Apr 29, 2026 09:45 UTC
-
ER doctors launch heart attack prevention on the spot
Prevention Recruiting nowThis study tests whether starting cholesterol-lowering treatment in the emergency department can prevent future heart problems. About 130 adults aged 40-75 who are at risk for heart disease but not yet on treatment will receive guideline-based care right in the ER. The goal is to…
Matched conditions: ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Apr 29, 2026 09:45 UTC
-
Blood test reveals how your immune system fights everyday triggers
Knowledge-focused Recruiting nowThis study looks at how the body's innate immune system—the part that responds first to germs—reacts to certain environmental factors. Researchers want to understand if these reactions can lead to chronic illnesses like asthma, heart disease, or cancer. Healthy volunteers aged 18…
Matched conditions: ATHEROSCLEROSIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Apr 29, 2026 09:46 UTC